Anjalee Khemlani
Yahoo Finance
New York, NY, United States
Contact Anjalee
Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
| Recent: |
|
| Past: |
|
Recent articles by Anjalee:
FDA 'too slow' amid baby formula crisis, commissioner testifies
FDA Commissioner Dr. Robert Califf testified before a U.S. House subcommittee about the ongoing baby formula shortage. → Read More
What's being done to address the baby formula shortage
The U.S. is experiencing a shortage of baby formula. The real turning point came in mid-February, after supply chain constraints were already pressuring the sector. → Read More
FDA expects baby formula shortage to improve in 'next couple of months'
FDA anticipates increased supply of baby formula in next couple of months. → Read More
What you hear in DC doesn't reflect what's going across the US: Fmr. US Surgeon General
Since leaving his post as U.S. Surgeon General in the Trump administration, Dr. Jerome Adams has taken to Twitter and other social media to advocate for... → Read More
FDA limits use of J&J COVID-19 vaccine over blood clot concerns
FDA follows CDC to recommend limitations to J&J COVID-19 vaccine use. → Read More
COVID-19: 'We might not be in a great spot in the fall': Moderna CEO
"This virus is not getting less infectious," Moderna CEO Stéphane Bancel told Yahoo Finance. "As you see more and more infectious variants ... We are not done with this virus mutating," he said. → Read More
Moderna prepares to sell COVID-19 vaccine privately as US delays booster call
Moderna awaits Congress's decision on funding boosters as well as the FDA's decision on which booster to produce, putting it in uncertain territory for 2022. → Read More
The pandemic 'pushed digital health forward like 15 years in three weeks,' health tech CEO
Technology in health care has skyrocketed as a result of the pandemic, though shaking out which platforms and strategies are the most useful is still a work in progress. → Read More
Fmr. U.S. Surgeon General on leaving COVID risk up to individuals
Individual burden has become the COVID-19 pandemic strategy, as U.S. officials see a path out of the pandemic phase. → Read More
Moderna files emergency authorization for kids' COVID-19 vaccine
Moderna starts its filing for an emergency use authorization of its COVID-19 vaccine in kids under 6 years. → Read More
Why Big Tech has struggled in the health-care space, according to Intel chair
Biofourmis is health care's new virtual care unicorn, with a valuation of $1.3 billion and CVS Health coming on board as an investor, the company announced Tuesday. → Read More
Mask mandate ruling is about as 'incoherent as possible:' Former Biden health adviser
Dr. Zeke Emanuel, vice provost of global initiatives at the University of Pennsylvania and former adviser to then–President elect Joe Biden, called a repeal of a federal mask mandate "as incoherent as possible." → Read More
Novavax nears FDA advisory meeting date
Novavax signaled a positive outlook for its vaccine pipeline Wednesday with announcements at the World Vaccine Congress and an update on its COVID-19 vaccine. → Read More
Cigna's Evernorth and Kaiser Permanente team up to expand coverage for remote employees
Cigna's Evernoth unit inks five-year deal with health care giant Kaiser Permanente, opening the door for a broadly-defined partnership. → Read More
US, WHO officials and experts now agree (sort of) on how COVID-19 spreads
The idea that the coronavirus spreads via the air has been known since 2020 by experts across the globe, but pinpointing the definition had remained a point of contention. → Read More
BA.2 surge could determine mask timeline for planes, trains: Fauci
Dr. Anthony Fauci says the next few weeks are critical to determining airline masking requirements. → Read More
Fauci: Omicron is to blame for vaccine delay for children 6 and under
Parents anxiously awaiting a vaccine for their younger children will have to be patient as the U.S. Food and Drug Administration works on two vaccine candidates' applications, Dr. Anthony Fauci told Yahoo Finance. → Read More
Serum Institute mulls Africa plant, mRNA future
The world's largest vaccine maker is eyeing Africa and mRNA ventures, but with caution. Serum Institute CEO Adar Poonawalla shares his thoughts with Yahoo Finance. → Read More
'FemTech' is booming as companies see women as health-care decision makers
FemTech is a growing force in healthtech, and the pandemic's focus on global equity has also created opportunities for emerging markets. → Read More
FDA 'slow-walking' Novavax authorization: Expert
Novavax fans, investors and patients alike, are frustrated by FDA's delays in authorizing COVID-19 vaccine. → Read More